Syensqo focuses on advanced materials and the Performance & Care business unit

Syensqo announced that it has initiated a strategic review of its Performance & Care segment. This is aligned with the company’s intention to focus on becoming a pure play specialty materials and advanced technologies company, with a greater exposure to structurally attractive end markets including aerospace and defence, electronics, healthcare, energy and advanced mobility applications.

“Since the start of the year, and along with the Board, we have undertaken a strategic assessment of our long-term direction and value creation priorities. In addition, we are fully focused on accelerating our growth trajectory, driving more consistent execution, sharpening our capital discipline as well as improving cash flow delivery,” said Mike Radossich, Chief Executive Officer of Syensqo.

“The announcement reflects our intention to further sharpen our portfolio, increase our focus on technologies where we see the strongest long-term growth opportunities and drive sustained, innovation-led differentiation. Accordingly, we will now evaluate a range of strategic options for the Performance & Care segment, with an emphasis on maximizing long-term value for our shareholders”, the CEO added.

The Company has not set a defined timetable for the strategic review and will provide further updates when appropriate. In addition, there can be no assurance or certainty that this process will result in any transaction, nor as to the terms or structure of any transaction.

Syensqo’s Performance & Care segment, comprising the Novecare and Technology Solutions global business units, is a global leader in surface chemistry solutions and specialty mining reagents serving the consumer care, agro, coatings and mining end markets. In 2025, the segment generated net sales of 2 billion euros and an underlying Ebitda of 358 million euros.